The Impact of a Federal Cigarette Minimum Pack Price Policy on Cigarette Use in the USA
Overview
Affiliations
Background: Increasing cigarette prices reduce cigarette use. The US Food and Drug Administration has the authority to regulate the sale and promotion-and therefore the price-of tobacco products.
Objective: To examine the potential effect of federal minimum price regulation on the sales of cigarettes in the USA.
Method: We used yearly state-level data from the Tax Burden on Tobacco and other sources to model per capita cigarette sales as a function of price. We used the fitted model to compare the status quo sales with counterfactual scenarios in which a federal minimum price was set. The minimum price scenarios ranged from $0 to $12.
Results: The estimated price effect in our model was comparable with that found in the literature. Our counterfactual analyses suggested that the impact of a minimum price requirement could range from a minimal effect at the $4 level to a reduction of 5.7 billion packs sold per year and 10 million smokers at the $10 level.
Conclusion: A federal minimum price policy has the potential to greatly benefit tobacco control and public health by uniformly increasing the price of cigarettes and by eliminating many price-reducing strategies currently available to both sellers and consumers.
Reactions to Pictorial and Text Cigarette Pack Warning Labels among Chinese Smokers.
Wang L, Yao X, Wang G, Du K Int J Environ Res Public Health. 2022; 19(18).
PMID: 36141520 PMC: 9517269. DOI: 10.3390/ijerph191811253.
Wang Y, Duan Z, Weaver S, Self-Brown S, Ashley D, Emery S Nicotine Tob Res. 2022; 25(4):699-708.
PMID: 36124654 PMC: 10032185. DOI: 10.1093/ntr/ntac216.
Tobacco Couponing: A Systematic Review of Exposures and Effects on Tobacco Initiation and Cessation.
Liber A, Sanchez-Romero L, Cadham C, Yuan Z, Li Y, Oh H Nicotine Tob Res. 2022; 24(10):1523-1533.
PMID: 35143678 PMC: 9575981. DOI: 10.1093/ntr/ntac037.
Research on lung cancer and its funding, 2004-2018.
Begum M, Urquhart I, Lewison G, Fouad F, Sullivan R Ecancermedicalscience. 2020; 14:1132.
PMID: 33281924 PMC: 7685768. DOI: 10.3332/ecancer.2020.1132.
A framework for identifying and mitigating the equity harms of COVID-19 policy interventions.
Glover R, van Schalkwyk M, Akl E, Kristjannson E, Lotfi T, Petkovic J J Clin Epidemiol. 2020; 128:35-48.
PMID: 32526461 PMC: 7280094. DOI: 10.1016/j.jclinepi.2020.06.004.